Acute myocardial infarction with lung cancer during treatment with gefitinib: the possibility of gefitinib-induced thrombosis.
Yamaguchi
K
K
First Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka, Japan.
Kanazawa
S
S
Kinoshita
Y
Y
Muramatsu
M
M
Nomura
S
S
D000230:Adenocarcinoma / Q000150:complications* / Q000628:therapy; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000628:therapy; D009203:Myocardial Infarction / Q000139:chemically induced*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib